Ryosuke Satomi

1.1k total citations
17 papers, 556 citations indexed

About

Ryosuke Satomi is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Ryosuke Satomi has authored 17 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 8 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Ryosuke Satomi's work include Lung Cancer Treatments and Mutations (7 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Cancer-related molecular mechanisms research (3 papers). Ryosuke Satomi is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Cancer-related molecular mechanisms research (3 papers). Ryosuke Satomi collaborates with scholars based in Japan and United States. Ryosuke Satomi's co-authors include Kenzo Soejima, Katsuhiko Naoki, Satoshi Yoda, Shinnosuke Ikemura, Sohei Nakayama, Hideki Terai, Takashi Sato, Tomoko Betsuyaku, Hiroyuki Yasuda and Junko Hamamoto and has published in prestigious journals such as PLoS ONE, Annals of the New York Academy of Sciences and Cancer Science.

In The Last Decade

Ryosuke Satomi

17 papers receiving 552 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryosuke Satomi Japan 12 323 259 206 192 41 17 556
Erica Stringer-Reasor United States 16 282 0.9× 231 0.9× 388 1.9× 268 1.4× 48 1.2× 48 738
Ngoc T. Hoang United States 6 274 0.8× 200 0.8× 155 0.8× 130 0.7× 22 0.5× 8 467
Jillian Wilhelmina Paulina Bracht Spain 14 381 1.2× 270 1.0× 283 1.4× 207 1.1× 63 1.5× 29 639
Tianqing Chu China 12 227 0.7× 277 1.1× 317 1.5× 163 0.8× 20 0.5× 46 606
Minhao Fan China 6 175 0.5× 268 1.0× 305 1.5× 134 0.7× 23 0.6× 11 531
James A. Onori United States 4 254 0.8× 236 0.9× 224 1.1× 123 0.6× 17 0.4× 5 500
Andrea Ravelli Italy 10 200 0.6× 251 1.0× 288 1.4× 106 0.6× 53 1.3× 15 543
Ella Liberzon Israel 8 313 1.0× 177 0.7× 111 0.5× 278 1.4× 24 0.6× 9 529
Lucia Trandafir Switzerland 11 280 0.9× 272 1.1× 247 1.2× 85 0.4× 26 0.6× 22 634

Countries citing papers authored by Ryosuke Satomi

Since Specialization
Citations

This map shows the geographic impact of Ryosuke Satomi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryosuke Satomi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryosuke Satomi more than expected).

Fields of papers citing papers by Ryosuke Satomi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryosuke Satomi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryosuke Satomi. The network helps show where Ryosuke Satomi may publish in the future.

Co-authorship network of co-authors of Ryosuke Satomi

This figure shows the co-authorship network connecting the top 25 collaborators of Ryosuke Satomi. A scholar is included among the top collaborators of Ryosuke Satomi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryosuke Satomi. Ryosuke Satomi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Watase, Mayuko, Takao Mochimaru, Hiroyuki Shinohara, et al.. (2023). Diagnostic and prognostic biomarkers for progressive fibrosing interstitial lung disease. PLoS ONE. 18(3). e0283288–e0283288. 11 indexed citations
2.
Katoh, Yuki, Tomonori Yaguchi, Takashi Iwata, et al.. (2022). Inhibition of stearoyl-CoA desaturase 1 (SCD1) enhances the antitumor T cell response through regulating β-catenin signaling in cancer cells and ER stress in T cells and synergizes with anti-PD-1 antibody. Journal for ImmunoTherapy of Cancer. 10(7). e004616–e004616. 61 indexed citations
3.
Nukaga, Shigenari, Hiroaki Murakami, Kazuma Yagi, et al.. (2021). A solitary pulmonary nodule caused by Mycobacterium avium with pleural effusion and pleuritis after transbronchial biopsy: a case report. Journal of Medical Case Reports. 15(1). 342–342. 1 indexed citations
4.
Satomi, Ryosuke, Mayuko Watase, Matsuo So, et al.. (2019). An Adult Case of Pulmonary Artery Sling Accompanied by Tracheobronchomalacia. Internal Medicine. 58(11). 1621–1624. 3 indexed citations
5.
Tani, Tetsuo, Katsuhiko Naoki, Hiroyuki Yasuda, et al.. (2019). A phase II trial of induction of erlotinib followed by cytotoxic chemotherapy for EGFR mutation-positive non-squamous non-small cell lung cancer patients. Cancer Chemotherapy and Pharmacology. 84(5). 1065–1071. 1 indexed citations
6.
Kobayashi, Keigo, Ichiro Nakachi, Katsuhiko Naoki, et al.. (2018). Real-world Efficacy and Safety of Nivolumab for Advanced Non–Small-cell Lung Cancer: A Retrospective Multicenter Analysis. Clinical Lung Cancer. 19(3). e349–e358. 45 indexed citations
7.
Funatsu, Yohei, Junichi Shiraishi, Takanori Asakura, et al.. (2016). Intimal Sarcoma of the Pulmonary Artery Treated with Pazopanib. Internal Medicine. 55(16). 2197–2202. 15 indexed citations
8.
Nakayama, Sohei, Kenzo Soejima, Hiroyuki Yasuda, et al.. (2015). FOXD1 expression is associated with poor prognosis in non-small cell lung cancer.. PubMed. 35(1). 261–8. 35 indexed citations
9.
Yoda, Satoshi, Kenzo Soejima, Junko Hamamoto, et al.. (2014). Claudin-1 is a novel target of miR-375 in non-small-cell lung cancer. Lung Cancer. 85(3). 366–372. 38 indexed citations
10.
Hamamoto, Junko, Kenzo Soejima, Katsuhiko Naoki, et al.. (2014). Methylation‐induced downregulation of TFPI‐2 causes TMPRSS4 overexpression and contributes to oncogenesis in a subset of non‐small‐cell lung carcinoma. Cancer Science. 106(1). 34–42. 17 indexed citations
11.
Terai, Hideki, Kenzo Soejima, Hiroyuki Yasuda, et al.. (2013). Activation of the FGF2-FGFR1 Autocrine Pathway: A Novel Mechanism of Acquired Resistance to Gefitinib in NSCLC. Molecular Cancer Research. 11(7). 759–767. 174 indexed citations
12.
Hamamoto, Junko, Kenzo Soejima, Satoshi Yoda, et al.. (2013). Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma. Molecular Medicine Reports. 8(2). 456–462. 54 indexed citations
13.
Kawakami, Yutaka, Tomonori Yaguchi, Hidetoshi Sumimoto, et al.. (2013). Cancer‐induced immunosuppressive cascades and their reversal by molecular‐targeted therapy. Annals of the New York Academy of Sciences. 1284(1). 80–86. 17 indexed citations
14.
Naoki, Katsuhiko, Kenzo Soejima, Hiroaki Okamoto, et al.. (2011). The PCR-invader method (structure-specific 5′ nuclease-based method), a sensitive method for detecting EGFR gene mutations in lung cancer specimens; comparison with direct sequencing. International Journal of Clinical Oncology. 16(4). 335–344. 39 indexed citations
15.
Yasuda, Hiroyuki, Kenzo Soejima, Sohei Nakayama, et al.. (2010). Bronchoscopic Microsampling is a Useful Complementary Diagnostic Tool for Detecting Lung Cancer. Lung Cancer. 72(1). 32–38. 17 indexed citations
16.
Yoda, Satoshi, Kenzo Soejima, Hiroyuki Yasuda, et al.. (2010). A phase I study of S-1 and irinotecan combination therapy in previously treated advanced non-small cell lung cancer patients. Cancer Chemotherapy and Pharmacology. 67(3). 717–722. 4 indexed citations
17.
Nakachi, Ichiro, Katsuhiko Naoki, Kenzo Soejima, et al.. (2010). The Combination of Multiple Receptor Tyrosine Kinase Inhibitor and Mammalian Target of Rapamycin Inhibitor Overcomes Erlotinib Resistance in Lung Cancer Cell Lines through c-Met Inhibition. Molecular Cancer Research. 8(8). 1142–1151. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erica Stringer-Reasor Breakdown of academic impact, for papers by Ngoc T. Hoang Breakdown of academic impact, for papers by Jillian Wilhelmina Paulina Bracht Breakdown of academic impact, for papers by Tianqing Chu Breakdown of academic impact, for papers by Minhao Fan Breakdown of academic impact, for papers by James A. Onori Breakdown of academic impact, for papers by Andrea Ravelli Breakdown of academic impact, for papers by Ella Liberzon Breakdown of academic impact, for papers by Lucia Trandafir
Rankless by CCL
2026